From: Genetic variants in myostatin and its receptors promote elite athlete status
Model | Controls n (%) | All high-elite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
AA | 211 (57.8) | 25 (49) | 1 | 0.016968 | ||
A/– | 137 (37.5) | 17 (33.3) | 1.05 | 0.55 | 2.01 | |
–/– | 17 (4.7) | 9 (17.6) | 4.47 | 1.8 | 11.08 | |
Dominant | ||||||
AA | 211 (57.8) | 25 (49) | 1 | 0.474748 | ||
A/– - –/– | 154 (42.2) | 26 (51) | 1.42 | 0.79 | 2.56 | |
Recessive | ||||||
AA - A/– | 348 (95.3) | 42 (82.4) | 1 | 0.004066 | ||
–/– | 17 (4.7) | 9 (17.6) | 4.39 | 1.84 | 10.46 | |
Overdominant | ||||||
AA - –/– | 228 (62.5) | 34 (66.7) | 1 | 1 | ||
A/– | 137 (37.5) | 17 (33.3) | 0.83 | 0.45 | 1.55 | |
Model | Controls n (%) | All elite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
AA | 211 (57.8) | 86 (57.3) | 1 | 1 | ||
A/– | 137 (37.5) | 60 (40) | 1.07 | 0.72 | 1.59 | |
–/– | 17 (4.7) | 4 (2.7) | 0.58 | 0.19 | 1.77 | |
Dominant | ||||||
AA | 211 (57.8) | 86 (57.3) | 1 | 1 | ||
A/– - –/– | 154 (42.2) | 64 (42.7) | 1.02 | 0.69 | 1.5 | |
Recessive | ||||||
AA - A/– | 348 (95.3) | 146 (97.3) | 1 | 0.56 | ||
–/– | 17 (4.7) | 4 (2.7) | 0.56 | 0.19 | 1.7 | |
Overdominant | ||||||
AA - –/– | 228 (62.5) | 90 (60) | 1 | 1 | ||
A/– | 137 (37.5) | 60 (40) | 1.11 | 0.75 | 1.64 | |
Model | Controls n (%) | All subelite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
AA | 211 (57.8) | 85 (65.9) | 1 | 0.25796 | ||
A/– | 137 (37.5) | 36 (27.9) | 0.65 | 0.42 | 1.02 | |
–/– | 17 (4.7) | 8 (6.2) | 1.17 | 0.49 | 2.81 | |
Dominant | ||||||
AA | 211 (57.8) | 85 (65.9) | 1 | 0.21014 | ||
A/– - –/– | 154 (42.2) | 44 (34.1) | 0.71 | 0.47 | 1.08 | |
Recessive | ||||||
AA - A/– | 348 (95.3) | 121 (93.8) | 1 | 1 | ||
–/– | 17 (4.7) | 8 (6.2) | 1.35 | 0.57 | 3.22 | |
Overdominant | ||||||
AA - –/– | 228 (62.5) | 93 (72.1) | 1 | 0.09222 | ||
A/– | 137 (37.5) | 36 (27.9) | 0.64 | 0.42 | 1 |